Skip to search formSkip to main contentSkip to account menu

cetiedil

Known as: alpha-Cyclohexyl-3-thiopheneacetic acid, 2-(hexahydro-1H-azepin-1-yl)ethyl ester 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1985
1985
Cetiedil, alpha-cyclohexyl-3-thiopheneacetic acid 2-(hexahydro-1H-azepin-1-yl)-ethyl ester, was found to inhibit the generation… 
1984
1984
In this report a sensitive gas chromatographic assay for cetiedil, a candidate antisickling agent, in human plasma is described… 
1983
1983
As part of a Phase I clinical trial, the clinical effects resulting from both single and multiple dose infusions of cetiedil, a… 
1982
1982
A number of agents that prevent sickling in vitro have been discovered during the past decade. In general, such agents act… 
1980
1980
The antisickling effect of cetiedil, alpha-cyclohexyl-3-thiopheneacetic acid 2-(hexahydro-1H-azepin-1-yl)-ethyl ester, has been… 
1980
1980
Cetiedil), originally a molecule used for treatment of some vascular diseases, exhibits several pharmacological effects. The… 
1980
1980
Therapeutic consequences of the enzyme induction phenomenon are briefly reminded. This action was investigated: 1.--In the rat…